Loading...
Interleukin‐22 in urinary tract disease – new experimental directions
Interleukin (IL)‐22 is expressed by immune cells in the urinary tract and IL‐22 receptor is expressed in urothelium and renal tubule cells. IL‐22 can be specifically targeted in the urinary tract or conditionally depleted in mice and targeted therapeutically in humans.[Image: see text]
Na minha lista:
| Udgivet i: | Clin Transl Immunology |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7276185/ https://ncbi.nlm.nih.gov/pubmed/32523694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1143 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|